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Abstract 
Mobile elements (MEs) are a major component in most higher eukaryotic genomes. MEs 
account over 50% of the human genome and consist of long interspersed elements (LINEs), 
Short interspersed elements (SINEs), and SINE-VNTR-Alu (SVAs) and long terminal repeats 
(LTR). MEs are known to play important roles in genome evolution and gene function and their 
roles include but are not limited to the generation of alternative splicing, insertional mutations, 
genomic instability and epigenetic regulation. Nevertheless, a systematic analysis of MEs 
contribution to transcriptomes in humans has not been conducted. In this study, we examined the 
MEs’ participation in the human reference transcriptome and the transcriptomes of many human 
tissues. Our results show that MEs contribute to 16% to the human reference transcriptome and 
on average ~24% to the full transcriptomes of human tissues. MEs’ contribution to human full 
transcriptomes varies from tissue to tissues and from person to person. MEs contribute to all 
exon features, but 60% of them are in non-coding regions. Also, they contribute to the transcripts 
of 4,402 protein coding genes, including regions, which are conserved among primates, 
mammals, and even vertebrates. We noticed that while Alus are the most prominent contributors 
to human transcriptomes involving mostly alternative transcripts, SVAs as the youngest ME 
class showed most active participation in protein coding genes with 78% contributing to the 
canonical transcripts. Furthermore, MEs also participate in post-transcriptional regulation by 
contributing to the formation of 16% miRNAs, ~9% of miRNA target sites, and at least 2,921 
double stranded RNA sites for RNA-editing.  In conclusion, our data demonstrate that MEs are 
very active participants in human transcriptomes by contributing to both non-coding RNAs and 
protein coding transcripts and to post-transcriptional regulation via miRNA and RNA-editing.  
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Chapter 1: Introduction and related literature review 
 
1.1 Mobile elements in the human genome 
Mobile elements (MEs), also interchangeably called Transposable elements (TEs), are 
DNA elements that are able to move throughout the genome using either retrotransposition or by 
self-splicing (Cordaux and Batzer, 2009). MEs were first described by Barbara McClintock in 
1953 while studying mosaic coloration in corn (McClintock 1953). MEs account for a large 
portion of plant genomes ranging from 40% to 80% (Meyers, et al., 2001) and was reported to 
account for close to 47% (Claros, et al., 2012) of the human genome (Lander 2001), this number 
was recently revised to be 52% (Tang, et al., 2016).  
MEs can be classified into two major categories based on their method of transposition: 
DNA transposons and retrotransposons. DNA transposons are MEs that transpose using a DNA 
intermediate. DNA transposons can be divided into three different sub-categories. The first 
category of DNA transposons (terminal inverted repeat elements) are the ones that can excise as 
double stranded DNA (dsDNA) and reinsert into a random site. The second category of DNA 
transposons (Helitrons) are the ones that replicate using the rolling-circle replication to replicate 
DNA and insert into the genome. The last class of DNA transposons (Polintons) use self-
encoded DNA polymerase to replicate and insert into the genome (Feschotte and Pritham, 2007). 
DNA transposons are estimated to account for ~3% of the human genome (Cordaux and Batzer, 
2009).   
Conversely, retrotransposons duplicate throughout the genome using an RNA 
intermediate which is reverse transcribed before inserting into a new genomic location.  
Retrotransposons are currently estimated to account for ~47% of the human genome (Cordaux 
and Batzer, 2009). There are two classes of retrotransposons, i.e., non-LTRs and LTRs. Non 
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Long Terminal Repeats (Non-LTRs) represent the majority of MEs present in the human genome 
and account for one-third of the human genome (Cordaux and Batzer, 2009). Non-LTRs can be 
further divided into three groups: long interspersed nuclear elements (LINEs), Short interspersed 
nuclear elements (SINEs), and SINE-VNTR-Alu (SVAs). 
LINEs are the most successful MEs in the human genome by total sequence length and 
account for ~ 17% of the human genome and are mainly represented by LINE 1 elements (L1s) 
(Cordaux and Batzer, 2009; Kazazian and Goodier, 2002). A full-length L1 element is ~6 
kilobases (kb) in length and it consists of a 5′ untranslated region (UTR) containing an internal 
RNA polymerase II promoter, two open reading frames (ORF1 and ORF2), and a 3′-UTR 
containing a polyadenylation signal. The ORF1 protein is a RNA-binding protein and ORF2 
protein has an activity of a reverse transcriptase and endonuclease. ORF1 and ORF2 proteins 
identify LINE and other non-LTR transcripts in the cytoplasm and transport them into the 
nucleus where they are retrotransposed into the genome using a process known as target-primed 
reverse transcription (TPRT) (Feng, et al., 1996).  
TPRT is a process in which the LINE endonuclease cleaves the first strand of target DNA 
and this generates a free 3' hydroxyl. This 3' hydroxyl is used as primer and a complementary 
DNA of the non-LTR RNA is made using L1 reverse transcriptase mechanism. Subsequently, 
the second strand of the target DNA is cut, at which the 5’ end of the non-LTR cDNA is 
attached, and then, the complementary strand of the cDNA is made, likely by DNA repair 
machinery. This leads to a new copy of the non-LTR element in the genome.  
SINEs are short DNA elements (<500 bases), and they have accumulated high copy 
numbers in mammalian genomes (Cordaux and Batzer, 2009; Deininger, 2011). Alu elements are 
the most abundant SINEs present in the human genome by copy number, constituting about 13% 
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of the genome. In primates, SINEs are mainly represented by Alu elements, which have inserted 
into primate genomes 65 million years ago. Alus are ~300 bp in length and contain an internal 
RNA polymerase III and have a poly(A) tail of variable length. SINEs are considered non-
autonomous since they are unable to code proteins and have to use L1-based TPRT machinery to 
retrotranspose into the genome (Luan, et al., 1993).  
SVAs are the youngest MEs with ~2700 copies in the human genome. They have evolved 
during the hominid evolution ~25 million years ago (Cordaux and Batzer, 2009; Wang, et al., 
2005). The SVA elements have a high sequence identity in the genome to each other, and this 
suggests that they have retrotransposed recently. A typical full length SVA is 2kb long, they are 
also unable to make functional proteins like SINEs, and they retrotranspose in the genome using 
LINE retrotransposition machinery. A SVA element is considered a repeat of repeats, in which 
the 5’ canonical consists of a sequence that is homologous to two antisense Alu elements 
(Hancks and Kazazian, 2010). This is followed by a GC variable number of tandem repeats 
(VNTRs) and a sequence that is homologous to the env gene and 5’ portion of the LTR of an 
ancient HERV-K10 element (Hancks and Kazazian, 2010). Then is followed by a 
polyadenylation (polyA) signal and a polyA tail (Hancks and Kazazian, 2010). A typical SVA 
retrotransposition exhibits the hallmarks of an L1 mediated retrotransposition (Ostertag, et al., 
2003; Schüller, et al., 2005). It is proposed that SVAs use the hexameric sites to transcribe 
themselves and successively, L1 retrotransposition mechanism identifies SVAs’ polyA tail, 
which enables the SVA element to retrotranspose into the genome (Ostertag, et al., 2003).   
Furthermore, when an SVA is being transcribed, it might bypass its own polyA signal 
and terminates at a downstream polyA signal. This might result in retrotranscription of extra 
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sequences flanking the 3’ end of SVAs to other genomic location, which is a phenomenon called 
“transduction”.   
The LTR retrotransposons are another group of retrotransposons that have long terminal 
repeats (LTR). One LTR sub-category is composed of endogenous retroviruses (ERVs), which 
account for approximately 8% of the human genome (Goodier 2008). They comprise of two long 
terminal repeats (LTRs), ranging from 300–1,200 bp in length, and are separated by three 
retroviral genes: gag, pol and env. Gag encodes the matrix and capsid proteins, pro encodes the 
protease, pol encodes the reverse transcriptase and integrase, and env encodes the surface 
envelope proteins. After infection of the retrovirus, a cellular tRNA molecule from the host is 
used as a primer by the ERV RNA to reverse transcribe into double stranded cDNA. Afterwards, 
integrase mediates the insertion of DNA genome into the host chromosome at random locations. 
If this integration takes place in germline cells, it will be passed on to next the generation via 
gametes carrying this allele (Bannert and Kurth, 2006).  
1.2 Overview of known functional impact of MEs 
MEs have driven the evolution of mammal genomes in a diverse way. Retrotransposons 
have shaped mammalian genomes by providing their sequences for a number of protein-coding 
exons of genes (Kazazian, 2004). ME insertions are sources of structural and genetic variation in 
the populations (Cordaux and Batzer, 2009). 
MEs may have played a role in important evolutionary biological processes. MEs play a 
major role in eukaryotic genome and can account of variety of mutations such as deletions, 
insertion, frameshifts inversions, translocations and duplications (Lonnig and Saedler, 2002). 
Mutations result from MEs transposing to genic region can affect gene expression (Deininger 
and Batzer, 2002; Kazazian and Goodier, 2002). The human genome has >50% of its sequences 
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derived from MEs and it is likely that the retrotransposition of these elements results in genetic 
variability within and between species (Deininger and Batzer, 2002). 
 Several studies have shown that MEs are insertional polymorphic in the human genome 
which has led to variation among the human population. These polymorphic MEs can play a role 
in the regulatory region. In particular insertional polymorphic MEs have had a positive effect, 
contributing to the plasticity and diversity of the primate genomes in particular with multi-gene 
families (Doxiadis, et al., 2008). Specifically, Alu elements are the largest family of MEs in the 
human genome. Alu repeats have accounted for insertional polymorphism in the human genome 
and this has been a source of genetic variation which has been useful in studying the relationship 
between different human population and evolution of genes (Roy, et al., 1999). Taken together 
this demonstrates that MEs continue to be important in genome evolution.  
1.3 Contribution of MEs to transcriptome and alternative splicing  
Alternative splicing is a mechanism by which a gene generates multiple mRNA variants. 
Alternative splicing is a mechanism that occurs in ~40-60% of genes in human (Lander, et al., 
2001). MEs have been shown to be responsible for a significant portion of alternative splicing 
(Abascal, et al., 2015; Cowley and Oakey, 2013). The process, in which intron sequences are 
retained as exons for a gene, is termed “exonization”. These exons occur in association with the 
presence of MEs since they contain cryptic donor and acceptor sites that cause the entire or part 
of an ME element to be retained as an exon. Alternative splicing variants that survive 
evolutionarily long periods become dominant and are likely to represent functional transcripts for 
these genes (Abascal, et al., 2015).  
Specifically, non-LTRs (L1, Alu, and SVA ) elements can introduce novel splice sites 
(Abascal, et al., 2015). In addition, Alu elements have weak, cryptic splice sites when they are 
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inserted into an intron of a gene (Deininger, 2011). However, Alu elements accumulate 
mutations in time, enabling these sites to be further activated and causing the Alu elements to be 
exonized (Deininger, 2011). Alus are responsible for most of the non-constitutively expressed 
alternative splice forms in human transcriptomes. 
In addition, MEs influence gene regulation by providing alternative promoter to genes 
(Cowley and Oakey, 2013). Also, MEs contain internal promoters, which can drive expression of 
nearby genes. Inappropriate activation of promoters by MEs can drive inappropriate gene 
expression and this mechanism has been associated with disease and cancer (Jordan, et al., 
2003). Furthermore, SVA insertion in the genome can trigger exonization which will result in the 
SVA element being present in the transcriptome (Hancks, et al., 2009).  
1.4 Regulation of ME expression in the genome  
MEs are relatively stable in the genome, i.e. are not transposing. Majority of MEs are 
unable to transpose since the host genome has developed methods to suppress their expression in 
the transcriptome (Huda, et al., 2010). DNA methylation is likely evolved as a mechanism 
against ME expression. In early embryogenesis, L1s are believed to actively transpose because 
there is a total genome demethylation process (Huda, et al., 2010). Chromatin modifications 
suppress ME expression through mechanisms including histone modification, DNA methylation, 
and alterations in chromatin packing and condensation (Huda, et al., 2010). Core histones are 
proteins that package DNA into nucleosomes. The histone tail extends outwards from 
nucleosome. Repressive histone modification is known to induce the formation of 
heterochromatin upon a ME insertion (Huda, et al., 2010). Modification of the histone tail alters 
the binding of protein factors and causes nucleosomes associated with MEs to be enriched for 
methylation, which is a signal for transcription repression and causes the formation of a 
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heterochromatin structure (Slotkin and Martienssen, 2007). It has been shown that mutation in a 
histone methyltransferase gene, SUV39 which is required for histone tail modification, leads to 
upregulation of ME expression in mouse embryonic stem cells. Histone tail modification in ME 
sequences prevents them from being transcribed (Slotkin and Martienssen, 2007). 
 In addition, ME expression is silenced by DNA methylation on the cysteine residues in 
CG dinucleotides. In most eukaryotes, the cysteine residue can be methylated and this 
methylation is copied onto the new strand during DNA replication. In mouse, de novo 
methylation on the cysteine residue is carried out by DNMT3 methyltransferase and a non-
catalytic homolog DNMT3L. This mechanism is responsible for methylation of MEs. In 
addition, DNMT1 is a DNA methyltransferase, which is responsible for maintaining DNA 
methylation. In DNMT1-deficient mice embryos, there is a high level of ME expression. These 
findings suggest that DNA methylation might be required for the epigenetic silencing of MEs 
(Slotkin and Martienssen, 2007).  
Another mechanism responsible for MEs silencing is RNA editing process. RNA editing 
is a process in which RNA nucleotides are converted from Adenosine to Iosine (A-I) in double 
stranded RNA. A-I conversion is a post-transcriptional process that occurs where Adenosine 
residues within the dsRNA are converted into inosine by the Adenosine Deaminase Acting on 
RNA (ADAR) proteins (Hundley and Bass, 2010). ADAR proteins are commonly bound to 
inverted repeat Alu (IRAlus) in the 3’-UTR  (Daniel, et al., 2015; Hundley and Bass, 2010). 
IRAlus are a pair of inverted Alu elements that reside within the same transcript, and they form 
imperfect stretches to perfect stretches of dsRNA (Elbarbary and Maquat, 2014). More than 90% 
of ADAR A-to-I editing in human cells occurs at IRAlus (Elbarbary and Maquat, 2014). This 
conversion of Iosine of the protein-coding transcript causes them to remain in the nucleus and 
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decreases translation efficiency. MEs are silenced and are responsible for silencing other MEs 
using various epigenetic silencing mechanisms (Tabara, et al., 1999).  
1.5 The role of MEs in post-transcriptional regulation 
RNA interference (RNAi) constitutes a class of processes that use short RNAs (approx. 
20–30 nucleotides) to recognize and manipulate complementary nucleic acids. RNAi-related 
pathways have roles in the control of gene expression, epigenetic modification, regulation of 
heterochromatin, and in the host-parasite interactions (Pedersen and Zisoulis, 2016). There are 
three classes of RNAi: piRNAs, siRNAs, and miRNA. These three classes of RNAi target 
complementary sequences by using a family of Argonaute proteins to degrade the 
complementary sequence. These Argonaute proteins are highly specialized small-RNA-binding 
molecules (Pedersen and Zisoulis, 2016). 
Micro RNAs (miRNA) are a class of RNAi that are first transcribed in the nucleus and 
are subsequently made into a stem-loop structure of 70nt (pre-miRNA). The pre-miRNA is 
exported into the cytoplasm where they are processed into a dsRNA of ~22nt  (Czech, et al., 
2008). Thereafter, the antisense RNA strand is loaded onto the Argonaute-protein complex and 
identifies the complementary strand (Ender and Meister, 2010). miRNAs regulate gene 
expression post-transcriptionally by targeting complementary mRNA sequences primarily in the 
3’-UTR regions. It has been shown that some miRNAs are generated by ME elements. 
Smalheiser and  Torvik hypothesized that miRNA hairpins were formed as a result of the 
insertion of two similar juxtaposing transposable elements in the opposite orientation into the 
same transcript (Smalheiser and Torvik, 2005). The resulting hairpin loop is processed by RNAi 
machinery and leads to the formation of functional miRNA derived from ME (Roberts, et al., 
2014; Smalheiser and Torvik, 2005).  
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SiRNAs are processed using similar pathways as for miRNA, but siRNA are processed 
from a secondary dsRNA structure in the nucleus (Czech, et al., 2008). The dsRNA structure is 
exported into the cytoplasm and subsequently loaded onto Argonaute protein complex. Then it 
follows a similar pathway as a miRNA to regulate gene expression. siRNAs target genes 
whose activity might promote genomic instability, and it has been suggested that siRNA 
contribute to genomic stability by genome-wide repression of MEs. Furthermore, it has also been 
shown that siRNAs silence ME through chromatin modification in Schizosaccharomyces pombe 
(Slotkin and Martienssen, 2007). siRNA can also lead to an alternative pathway, in which the 
siRNA will form a complex with Argonaute-family proteins. This complex will be guided to a 
nascent ME transcript. Subsequently, the nascent ME transcript is cleaved and this recruits a 
methyltransferase (Slotkin and Martienssen, 2007). This methyltransferase can then modify 
chromatin structure of the cleaved ME and this will result in a heterochromatin structure, which 
will prevent the ME from being expressed.   
PiwiRNA is another form of RNAi, which is linked with epigenetic silencing and post- 
transcriptional silencing of retrotransposons. piwiRNA is a single stranded RNA that interacts 
with piwi protein. piRNA is thought to silence germline MEs since they are complementary to 
the MEs. MEs are thought to be parasitic to the host and RNAi is an evolutionary mechanism to 
prevent MEs from expressing themselves. MEs and the host genomes are engaging in an 
evolutionary arms race, where each side steals mechanisms to aid in their struggle. In the 
evolutionary arms race the host genome use MEs to generate RNAi to prevent them from 
spreading into the genome (Czech, et al., 2008; Huang, et al., 2014).  
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1.6 Diseases associated with ME insertion and expression 
Diseases can be caused due to inappropriate expression or mobilization of ME elements 
in the genome. Specifically, de novo insertion of L1 elements into the exons of the gene can 
result in hemophilia, Duchene muscular dystrophy (DMD), and colon cancer (Kazazian, et al., 
1988; Miki, et al., 1992; Yoshida, et al., 1998). L1 insertion into the exon 14 of factor VIII gene, 
along with the creation of target site duplication of 12-13nt can cause Hemophilia A (Kazazian, 
et al., 1988). Hemophilia A is a genetic disorder caused by missing or defective clotting factor 
which results in severe and frequent bleeding.  Furthermore, insertion of L1 element in the DMD 
gene can affect the stability of the dystrophin transcript and result in muscular dystrophy 
(Yoshida, et al., 1998). Also, de novo insertion of L1 into the last exon of Adenomatous 
Polyposis Coli (APC) gene disrupts by creating target site duplication and ME insertion (Miki, et 
al., 1992). The APC gene is a tumor suppressor gene and disruption of the gene can cause 
sporadic colorectal tumors (Miki, et al., 1992).  
Neurofibromatosis type 1 (NF1) is a disease characterized by neurofibromas (nerve 
tumors), bone deformities and learning disabilities. Moreover, it has been shown that insertion of 
Alu elements in the intron of the NF-1 genes leads to a deletion and a reading frame shift in the 
downstream exons, and this has been associated with neurofibromatosis (Wallace, et al., 1991). 
Also, it has been shown that ectopic recombination of Alu elements has led to the genomic 
rearrangement of Breast Cancer 1 (BRCA1) gene (Wallace, et al., 1991; Yap, et al., 2006). 
Genomic rearrangement of BRCA1 has been associated with ovarian and breast cancer in 
women. Insertion of Alu elements in BRAC1 gene has been associated with ovarian and breast 
cancer (Wallace, et al., 1991; Yap, et al., 2006).   
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It has also been shown that SVA insertions can cause disease. For instance, a SVA 
insertion in the exon 9 of the Bruton’s tyrosine kinase gene was shown to lead to loss of protein 
and causes X-linked agammaglobulinemia, a genetic disease that affects the body’s ability to 
generate mature B cells to fight infections (Conley, et al., 2005). These examples indicate that 
MEs can cause diseases and cancers by inserting themselves into protein coding or regulatory 
regions.   
1.7 Characterization of human transcriptomes 
Detailed and accurate documentation of the entire transcriptomes has been a very 
challenging task in the past. The advent of high throughput technologies, including microarray 
and most notably the recent RNA-seq technology, as well as a few related large-scale 
international efforts have greatly improved our understanding of the transcriptomes for many 
species. Among the latter, the GENCODE project is the most comprehensive annotation project, 
which has identified functional elements that are validated experimentally, manually and 
computationally. The GENCODE project started in 2003 and its goal was to identify the 
functional elements in the human genome by improving the coverage and accuracy of the 
protein-coding annotation including alternatively spliced variants, non-coding transcripts, and 
pseudogenes in the human genome. It also provides the most comprehensive annotation of long 
non-coding RNA (Harrow, et al., 2012). The GENCODE annotation was created by merging the 
manual gene annotation and the automated gene annotation. The Reference sequences (RefSeq) 
project is a NCBI project that has curated a collection of transcript sequences (Pruitt, et al., 
2007). The RefSeq and GENCODE project has provided us with most compressive transcript 
annotation for humans and using the combination of data from both projects has allowed us to 
identify the role of MEs in the human transcriptomes.  
21 
 
1.8 RNA-Sequencing for analysis of transcriptomes 
The transcriptome is the complete set of RNA transcripts in a cell under a specific 
developmental and physiological state. Analysis of transcriptome examines the identity as well 
as the quantities of RNA transcripts. Understanding the transcriptome is critical for interpreting 
the functional elements of the genome (Wang, et al., 2009). Previously, microarray technology 
was used to determine the transcriptome. Microarray technology measures the binding of 
nucleotide sequences attached to a solid surface to set of sequence probes and it has been 
extensively used to profile the expression of genes in human and many other species 
(Okoniewski and Miller, 2006). This approach has several limitations which include: the probe is 
capable of hybridizing to more than one transcripts that share sequence similarity and results in 
cross-hybridization; unable to detect transcripts of novel genes and novel splicing forms and 
transcripts at extremely high or low levels. The newer next-generation sequencing (NGS)-based 
RNA-sequencing (RNA-seq) technologies offer to overcome these limitations and are replacing 
the microarray technologies for the analysis of transcriptomes. 
RNA-seq is a process in which the total population of RNA is converted into cDNA 
fragments. The fragments are then sequenced using any NGS platform. NGS are high throughput 
sequencing technologies that produce sequences in parallel at massive scales. NGS technologies 
offer lower cost than the traditional Sanger sequencing. The 2 main NGS technologies that 
currently dominate the commercial market are Illumina (Solexa), and Ion Proton (Ion Torrent). 
Following sequencing, the resulting reads are aligned to a reference genome or a reference 
transcriptome. Subsequently, the expression of a particular gene can be calculated by identifying 
the number of reads that mapped to each locus (Wang, et al., 2009). Using, RNA-seq technology 
allows enhanced detection of gene transcripts. Furthermore, RNA-seq also allows researchers to 
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understand alternative transcripts. Usually, MEs are disregarded as non-functional and are not 
annotated in the reference transcriptome. Nonetheless, using RNA-seq technology will allow us 
to identify and measure the expression of MEs not annotated in the reference transcriptome and 
understand the role of MEs in the transcriptomes of all tissues using human as a model.   
1.9 Objectives 
The overall goal of this study is to examine the MEs’ participation in human 
transcriptomes by utilizing the most updated annotation of genes, transcriptome, and MEs in the 
human genomes, as well as a wealth of RNA-seq based transcriptome data available for many 
human tissues. Two specific objectives include: 1) to provide a detailed documentation of MEs’ 
contribution to the reference human transcriptome generated from integrating the GENCODE 
and RefSeq gene annotations; 2) to determine the contribution of MEs to human transcriptomes 
using publicly available RNA-seq data for different human tissues. This will be the first study to 
perform a systematic analysis of MEs’ contribution to the human transcriptomes and is expected 
to provide novel insights about the functions of MEs in the human genome. 
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Chapter 2: Methods and Materials  
2.1 Generation of a non-redundant exon list for the human genome. 
A non-redundant human gene exon list was created from the GENCODE version 23 file 
by merging overlapping exon positions from different transcript isoforms for each GENCODE 
gene ID. Two or more exons for a particular gene were determined as overlapping if the exons’ 
start and end positions intersected with each other. Each exon is annotated with a feature (CDS, 
3’-UTR, 5’-UTR, NR representing Coding DNA Sequences, 3’ untranslated regions, 5’ 
untranslated regions and non-coding RNA, respectively) based on its corresponding annotation 
in the GENCODE file (Appendix Table 1). Exons were annotated as non-coding (NR) if they 
had a non_coding or a processed_transcript feature in the GENCODE annotation file. Non-
coding transcripts are transcribed from DNA but not translated into proteins and also protein 
coding genes have transcripts that are non-coding.  In situations where two exons with different 
features overlap with each other, the non-redundant list comprised of the start and end positions 
of the feature that had the highest priority, and then the start and end position of the secondary 
feature for the remaining region(s). The priority for exons is as follows: CDS, UTR, NR based 
on their functional importance in gene function. For instance, exons overlapping between UTR 
and CDS, the non-redundant list will record the complete CDS start and end position and the 
remaining non-overlapping UTR region. This priority of non-redundant exon was given to CDS 
region as it encodes for a protein with a likely higher functional importance than UTR. In 
addition, each exon was given a gene/transcript biotype (e.g. protein coding, non-coding, etc.) 
based on its corresponding annotation in the GENCODE file.  
Similarly, a non-redundant exon list for RefSeq was created following the same criteria’s 
as the GENCODE non-redundant exon list. RefSeq annotations were obtained from the UCSC 
Genome Browser (O'Leary, et al., 2016). Subsequently, unique RefSeq gene were added to the 
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GENCODE non-redundant list. RefSeq genes were considered unique if their start and end 
position did not overlap with any genes in the GENCODE file.  
Table 1 lists the tools/databases used to identify the role of MEs in the transcriptome.  
Table 1. Tool and data sources for human genome sequences and gene annotation 
Data Source/Tools Reason used Reference 
GENCODE v23 &  
RefFlat version for 
hg38 
Was used to create non-
redundant human gene exon 
list 
http://www.gencodegenes.org/about.html 
O'Leary et al., 2016 
Repeat Masker  Was used to identify ME in the 
Reference Transcriptome 
http://repeatmasker.org 
2.4.0 Basic local 
alignment search 
tool (Blast) 
Was used to identify sequence 
similarity 
(Camacho, et al., 2009) 
RPS-BLAST (rpsb) 
program 
Was used to identify 
Conserved Domains in ME-
CDS 
(Marchler-Bauer, et al., 2007) 
DIANA-TarBase 
v7.0 
Was used to identify the 
location of miRNA target 
sequences in the 3’-UTR of the 
human genome 
(Vlachos, et al., 2015) 
miRNA database 
(miRbase 21) 
Was used to identify location 
of primary and mature miRNA 
in the human genome 
(Kozomara and Griffiths-Jones, 2014) 
BEDTools intersect 
2.26.0 
Was used to identify 
overlapping ME elements in 
the human genome against 
RNA-seq reads 
Quinlan & Hall, 2010 
RNA fold 2.3.4 Was used to determine the 
dsRNA in the 3’-UTR 
(Lorenz, et al., 2011) 
Tophat_v2 Was used for mapping RNA-
seq reads to the human 
reference genome 
(Kim, et al., 2013) 
 
SAMtools 1.6  Was used to identify and filter 
out secondary Reads in RNA-
seq 
(Li, et al., 2009) 
Cufflinks v2.2.1 Was used to assemble the 
RNA-seq and calculate  
(Trapnell, et al., 2012) 
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2.2 Cross-mapping between exons and mobile element 
To identify MEs’ participation in the transcriptome, the RepeatMasker annotation for the 
human reference genome version 38 (hg38) was obtained (http://repeatmasker.org). 
Microsatellite, low complexity and tandem repeat elements were filtered out and only MEs were 
retained from the RepeatMasker entries. Subsequently, a position overlap was performed 
between the MEs and the non-redundant exons using an in-house Perl script. During the 
overlapping process, one ME entry may overlap with multiple exons. To generate a non-
redundant ME list non-overlapping exons, only one exon feature designation was used based on 
the priority order for exon feature as follows: CDS, UTR and NR. This overlapped non-
redundant ME list involving in exons (transcriptome) was referred to as ME-Transcriptome.  
2.3 Analysis of ME coding sequences 
MEs that overlap with CDS regions (ME-CDS) were identified from the ME-
transcriptome file. As a result, ME-CDS that were greater than 30 bases in length were retrieved 
from the hg38 human genome file. Subsequently, a blastx (translated nucleotide to protein 
sequences) of the ME-CDS, along with 100 bp flanking the MEs sequences on both sides was 
performed against the protein sequences for Pan troglodytes (Chimpanzee), Macaca mulatta 
(Rhesus monkey), Mus musculus (Mouse), Ornithorhynchus anatinus (Platypus), Gallus gallus 
(Chicken), and Danio rerio (Zebrafish) in the NCBI nr protein database (O'Leary, et al., 2016). 
Blastx hits with a maximum e-value of 0.1, sequence similarity greater than 45% and bit score 
greater than 40 were selected and processed with an in-house Perl script. For each ME-CDS, a 
conservation score was calculated as the number of species containing detectable homologous 
sequences in the proteins for the entire ME-CDS. For instance, if one particular ME-CDS is 
present in all six species, then a conservation score of 6 is given to that ME-CDS. Consequently, 
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if no homolog of a ME-CDS is detected in any of the six species then conservation score of zero 
is given and the ME-CDS is considered human-specific.   
To assess the rate of MEs participating in CDS, a ratio of human-specific and nonhuman-
specific was calculated for each MEs class as DNA transposons, LTRs, LINEs, SINES, and 
SVAs.   
2.4 Analysis of MEs in canonical gene transcripts 
To identify the number of ME-CDS in the  canonical transcripts, a list of canonical 
transcript sequences for the human transcriptome was created based on the ENSEMBLE criteria 
as listed below (Aken, et al., 2016): 
1. The longest consensus coding sequence (CCDS) with no stop codons was chosen 
2. If that was not present then, the longest Ensembl/Havana merged translation 
sequence with no stop codons was chosen.  
3. If that was not present then, longest coding sequence with no stop codons was chosen 
4. If no translation was present, then the longest non-protein-coding transcript was 
chosen.  
Subsequently, a blat was performed for the ME-CDS sequences against these canonical 
transcript sequences with a minimum identity of 100% (Kent, 2002). Also, gene ontology on 
biological processes and molecular functions was performed on genes in ME-CDS using 
the Database for Annotation, Visualization and Integrated Discovery (DAVID) version 6.8 
(Huang, et al., 2009). 
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2.5 Analysis of MEs’ contribution to miRNA and miRNA target sites 
MicroTarbase is a database that covers both computational and manually curated miRNA 
gene interaction and is one of the largest databases of miRNA gene interaction. To identify the 
contribution of miRNA target sites by MEs present in the transcriptome, the miRNA database 
was downloaded from miroTarbase 
http://diana.imis.athenainnovation.gr/DianaTools/index.php?r=microT_CDS/index  
(Paraskevopoulou, et al., 2013). Successively, the human-specific miRNA target sites with a 
confidence score greater than  0.7 were extracted. Then the miRNA genome positions were 
converted from hg19 build to hg38 build using the liftOver tool provided on the UCSC genome 
browser website (http://genome.ucsc.edu/cgi-bin/hgLiftOver). Then, MEs in the 3’-UTR 
overlapping with miRNA target site was identified using BEDtools intersect (Quinlan and Hall, 
2010).  
Also, primary and mature miRNA location was identified in the hg38 genome using 
miRBase 21 databases (http://www.mirbase.org/). The miRBase database contains 
experimentally validated primary and mature locations of all miRNA sequences in the human 
genome. Afterwards, a position overlap of MEs in transcriptome using BEDtools intersect was 
performed against all the primary and mature miRNA positions.  
2.6 Analysis of MEs in protein conserved domains 
Conserved Domains in ME-CDS were identified using the RPS-BLAST (rpsb) program 
(Marchler-Bauer, et al., 2007). Rpsb is a multiple sequence alignment search tool that performs a 
sequence alignment of a CDS DNA or protein sequence query against the sequences in the NCBI 
protein conserved domain database. The rpsb program was run using a e value of 0.01 and the 
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ME-CDS sequences were used as the query sequences and human protein sequence was used as 
the database. This database and tool allowed the identification of MEs in the functional domain.  
2.7 Identification of double-stranded dsRNA structure in the transcriptomes 
Double stranded RNA structures were identified for MEs in the 3’-UTR sequences for 
the human reference transcriptome using the default setting in the RNAfold program (Lorenz, et 
al., 2011). The RNAfold program identifies intramolecular folds through energy minimization 
and pairs are between two bases have a minimum probability of 10E-6. The RNAfold program 
identified paired RNA transcripts and stored them in a post script file (ps). Consequently, for 
each transcript, the ps file was analyzed to identify where a pair of MEs consists of sequences 
greater than or equal to100bp. It has been shown that when two MEs in opposite orientation are 
inserted and form a pair of 100 bp or more in the 3’-UTR, they have been shown to form 
Inverted Repeats (IR) (Blango and Bass, 2016; Deininger, 2011). Through the above process, 
Inverted MEs (IRME) were identified.  
2.8 Sequence preference of ME consensus in the transcriptome  
To decide whether certain parts of the ME sequences were preferentially used in 
transcriptomes, the frequencies of ME regions used in transcriptomes were surveyed by utilizing 
the begin and end position information relative to the respective ME consensus sequences 
included in the RepeatMasker file. Subsequently, the rate of usage in the transcriptome for a 
selected list of ME consensus sequence were calculated in the reference transcriptome. 
2.9 Profiling MEs expression in transcriptomes based on RNA-seq data 
Eighty-six RNA-seq samples across 23 different human tissues from the NCBI SRA 
database were retrieved (Appendix Table 2). Subsequently, these sequences were mapped to the 
to the primary assembly of the hg38 genome sequences (excluding alternative assemblies) using 
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tophat2 (Kim, et al., 2013) with default setting and with secondary reads filtered out using 
SAMtools (Li, et al., 2009). The fragments per kilobase of transcript per million mapped reads 
(fpkm) values were calculated for all MEs expressed in human genome based on the following 
formula:   
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑅𝑒𝑎𝑑𝑠 𝑓𝑜𝑟 𝑎 𝑟𝑒𝑔𝑖𝑜𝑛
(𝑙𝑒𝑛𝑔𝑡ℎ 𝑜𝑓 𝑟𝑒𝑔𝑖𝑜𝑛 ∗ 𝑡𝑜𝑡𝑎𝑙 𝑚𝑎𝑝𝑝𝑒𝑑 𝑟𝑒𝑎𝑑𝑠) ∗ 10^9
 
In addition, cufflinks v2.2.1 (Trapnell, et al., 2012) was used with the default setting to 
calculate the fpkm values of genes in the case of HSNAT in the RNA-seq data for the 86 RNA-
seq samples. The total length of non-redundant expressed genomic sequences in each 
transcriptome (i.e., a RNA-seq dataset) was calculated using an in-house Perl script. 
Subsequently, MEs overlapping with the non-redundant genomic exon list were identified using 
BEDTools intersect (Quinlan and Hall, 2010), and their total non-redundant length was 
calculated using an in-house perl script. Furthermore, the intergenic region was identified based 
on a region that is greater than 1000 bp away from any annotated transcript regions. MEs in the 
intergenic region were identified by overlapping the intergenic region using BEDTools intersect. 
MEs in the intergenic region with a fpkm greater than 0 were identified and visualized.  
2.10 Computational analysis  
All the data were generated and analyzed by using the computer systems on 
SHARCNET, which are part of the Compute Canada high performance computing facilities 
(https://www.sharcnet.ca).    
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Chapter 3. Results 
3.1 MEs contribute to the human reference transcriptome with SVA being the youngest 
and most active participant.  
 
3.1.1 Overview of MEs’ contribution to human reference transcriptome  
To examine the contribution of MEs to the human transcriptome, we first generated a 
non-redundant reference set of human transcripts (referred as “Reference Transcriptome” 
hereafter) by combining the latest versions of gene annotation documented in GENCODE and 
RefSeq (Harrow, et al., 2012). The merged and non-redundant list of human GENCODE and 
RefSeq reference transcriptome, is 120.6 Mbp in total length, among which 19.2 Mbp or 15.9% 
are contributed by MEs. Based on the GENCODE and RefSeq annotation, we divided all exon 
regions into 4 categories (or exon features): 3’-UTR, 5’-UTR, and Coding DNA Sequence 
(CDS) for protein coding genes and non-coding RNAs (NRs) (Table 2). The NR genes are 
transcribed, but not translated into protein. Furthermore, GENCODE and RefSeq collectively 
cover a total of 49,204 non-redundant genes, representing 20,410 protein coding genes and 
28,794 NR genes.  
In association with the human reference transcriptome, MEs contributed to the transcripts 
of 31,672 genes, representing 12,538 (61.4%) protein-coding genes and 19,134 (66.4%) NRs 
(Table 2). By sequence length, MEs contributed a total of 19.2 Mbp in sequence to the reference 
transcriptome, representing 15.9% of the transcriptome, 7.5/80.4 Mbp (9.3%) of the protein 
coding transcripts and 11.7/40.2 Mbp (29.1%) for NR transcripts (Table 2). MEs contribute to 
genes in different ways: partially or entirely overlapping with exons or with an entire transcript 
(Fig. 1). For instance, a LINE element contributes to a splice form to the (Cyclin Dependent 
Kinases) CDK11B gene (Fig. 1A), showing the ME contributing to the alternative transcript of 
the gene.  
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Table 2. A summary of MEs’ contribution to the human reference transcriptome. 
  
Reference 
Transcriptome 
(Mbp) 
ME in 
Transcriptome 
(Mbp) 
% 
Contribution 
by length* 
# Reference 
Transcriptome 
genes 
# ME 
Contributio
n by genes 
% 
Contributi
on by 
genes** 
Protein 
Coding 
Genes 
80.4 7.5 9.3 20,410 12,538 61.4 
NR 40.2 11.7 29.1 28,794 19,134 66.4 
All 120.6 19.2 15.9 49,204 31,672 64.4 
 * % Contribution by length is calculated by dividing reference transcriptome (Mbp) by ME length in the 
reference transcriptome;  
** % Contribution by genes was calculated by dividing the number of genes represented in the Reference 
Transcriptome by the number of genes with MEs contributing to their transcripts.  
 
In examining the different exonic regions divided into 5’-UTR, CDS, 3’-UTR, and NR, 
over half (61%) of MEs contribute to NR transcripts, but a large component (39%) also 
contribute to protein-coding transcripts (Table 3). The non-coding transcripts account for 40.2 
Mbp in total length, out of which MEs contribute 11.7 Mbp (29%) (Table 3).  
For protein-coding transcripts, MEs contribute to all three parts (5’-UTR, CDS, and 3’-
UTR) with most participated in the 3’-UTR (32.2%) followed by 5’-UTR (4.6%) and CDS 
(2.1%) (Table 3). There are more MEs in the 3’-UTR than in 5’-UTR, and this might be 
attributed to the fact that 3’-UTR regions are much longer than 5’-UTRs in general (Table 3).  
Among the different types of MEs, by total length of the transcriptome SINEs contribute 
the most (6.6%) to the reference transcriptome, followed by LINE (4.6%), LTR (3.0%), DNA 
(1.6%), and SVA (0.1%), and by the percentage of MEs in the ME-transcriptome, SINEs 
contribute most (41.6%), followed by LINE (28.8%), LTR (18.9%), DNA (10.3%) and SVA 
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(0.4%) (Table 4). A similar pattern is seen when looking at the number of MEs in the 
transcriptome and MEs in the human chromosomes (Appendix Table 3, Appendix Fig. 1). 
However, SVA are not present in chromosome Y. In addition, SINEs contribute to the most 
number of genes compared to other ME classes (Table 4). This indicates that SINEs are the most 
prevalent class of MEs in the human reference transcriptome by both total sequence length 
contributed and by the number of genes involved.   
We also compared the average length of MEs expressed in the reference transcriptome. It 
is interesting to notice that while the full ME length differ greatly among the different ME 
classes, the ME-exon lengths are not dramatically different among the classes with DNA, LTR, 
LINE and, SINE are the same in the range of 130 to 200 bp, likely related to average length of all 
exons (Table 4).  In contrast, the average exon length of SVAs stands out to be longer than that 
of the other ME classes at over 300 bp, while SVAs are not the longest among the ME classes 
(Table 3). 
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Figure 1. A screenshot of the UCSC genome browser showing examples of MEs’ participation 
in the human reference transcriptome. A)  LINE contributes to a splice form of CDK11B gene; 
B) SINE contributing partially to a PEX16 gene exon; C) LTR element contributing entirely to 
the antisense ERW1 gene transcript.  
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Table 3. A summary of MEs’ contribution to reference transcriptome by exon feature.    
Exon 
Features 
Total Reference 
Transcriptome 
(Mbp) 
ME-Transcriptome 
length (Mbp) 
% MEs to 
Exon 
Features  
*% MEs in total 
ME-Transcriptome 
CDS  35.1 0.4 1.1 2.1 
3’-UTR 36.3 6.2 17.1 32.2 
5’-UTR 9.0 0.9 10.0 4.6 
NR 40.2 11.7 29.1 60.9 
All  120.6 19.2 15.9 100 
*%ME in transcriptome was calculated as exon feature length in ME-Transcriptome divided by total 
length of ME-Transcriptome, e.g. for CDS, it is (0.4/19.2 Mbp) *100=2.1%.  
 
 
Table 4. A summary of MEs’ contribution by class to reference transcriptome. 
* Average Mobile element portion is calculated by dividing total ME exon length by the number of MEs; 
** %contribution in transcriptome was calculated based on ME type length in the transcriptome divided 
by total length of transcriptome (120.6 Mbp)  
 
 
ME 
Class 
Total 
Count 
Total ME-
exons length 
(Mbp) 
Unique 
genes 
% in all 
ME- 
exons 
AVG ME-
exon length 
(bp)* 
**% Contribution 
in Transcriptome  
DNA 14756 2.0 10000 10.3 134 1.64 
LTR 18290 3.6 10371 18.9 199 3.0 
LINE 32734 5.5 16681 28.8 169 4.6 
SINE 51346 8.0 20938 41.6 156 6.6 
SVA 219 0.1 209 0.4 312 0.1 
All 117345 19.2 NA 100 164 15.9 
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3.1.2 SVAs are the most active participants in protein coding genes and CDS-exons 
By the total length of contribution to the transcriptome, as shown in Table 4 and Fig. 2, 
SINEs are the most prevalent ME class in all types of exonic regions and SVAs contributing to 
the least.  The distribution pattern seems to be quite similar among all types of exonic regions, 
suggesting there was no strong bias for a particular ME class among different exon regions (Fig. 
2B). Yet, when the ME contribution to the transcriptome was normalized based on their 
respective total length in the genome, the picture became quite different with SVAs standing out 
as a ME class that has the highest ratios contributing to transcriptome (Fig. 2C) and the highest 
average length of ME-exons in bases pairs (313 bp) (Table 4). The ratio of SVAs contributing to 
transcriptome is no longer the lowest among ME classes for all exon features (Fig. 2C), and in 
CDS, SVAs showed highest ratio (0.3 %), which is more than 3 times higher than for that of 
DNA transposons, which represent the 2nd highest (0.06%) (Fig. 2C insert). This is a highly 
unexpected observation since SVA is the youngest ME class in the human genome present only 
in the hominid group of the primates. In contrast, other ME types are much older with their 
presence spanning the evolution of entire primates (SINE), or mammalians (LINE and LTR) or 
even vertebrates (DNA).  
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Figure 2. The composition of MEs in the reference transcriptome based on total number of 
MEs present in different exon features. Protein coding transcripts includes Coding DNA 
Sequence (CDS), Untranslated Regions (UTR) and non-coding transcripts (NR) for non-coding 
genes. A) Total ME length in each exon feature with the zoomed in inserts below showing the 
data for the CDS and 5’-UTR sections; B) ME type composition in percentage for each exon 
feature; C) ME-exon length normalized to the respective ME genomic length.  The zoomed in 
insert below represented by the red circle shows the data for CDS and 5’-UTR sections.   
 
3.2 MEs’ participation in protein coding 
Our data showed that MEs have played a critical role in the evolution and function of the 
gene by directly participating in protein coding regions. Collectively, MEs have contributed to 
the CDS regions (ME-CDS) for a total of 4,402 genes based on the reference transcriptome.  
Many of these ME-CDS are conserved across multiple species. Among those, the longest MEs 
involved in CDS are 1970 bp, 1811 bp, 857 bp, 377 bp and 346 bp for DNA, LTR, LINE, SVA, 
and SINE, respectively (Fig. 3). In the examples shown in Fig. 3, a DNA transposon contributes 
entirely to the CDS portion of Family with Sequence Similarity (FAM200B) gene (Fig. 3A). 
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FAM200B is a protein-coding gene associated with nucleic acid binding (Pundir, et al., 2017). In 
the case of Endogenous Retrovirus Group 3 Member (ERV3-1) gene, a LTR contributes 1811 bp 
to be the entire CDS region of ERV3-1 gene (Fig. 3B).  ERV3-1 is a gene derived from a HERV, 
which integrated into the primate genome very early on (RefSeq, Jul 2008). A LINE contributes 
to a portion of a CDS region for LINE1 Type Transposase Domain Containing 1 (L1TD1) gene 
(Fig. 3C). In the case of Zinc Finger Protein 66 (ZNF66) gene, a SINE contributes 366 bp to its 
CDS. The product of ZNF66 is associated with a nucleic acid binding (Pundir, et al., 2017). 
Lastly, a SVA contributes entirely to a computationally annotated gene, AC017081.1 (Fig. 3D). 
These examples indicate that MEs are not only contributing to the non-coding portion of the 
transcriptome but are also contributing to the protein coding.   
  
Figure 3. Examples of MEs contributing to CDS of genes. A screenshot of ME-CDS were 
shown in the UCSC Genome Browsers with the gene structure and RepeatMasker tracks 
displayed.  A) DNA transposon contributes 1970 bp to the entire FAM200B CDS; B) A LTR 
contributes 1811 bp to be the entire CDS region of ERV3-1; C) A LINE contributes 857 bp to 
part of the CDS of L1TD1; D) A SINE contributes 346 bp to the CDS of ZNF66 gene; E) A SVA 
contributes 377 bp to the entire computationally annotated gene, AC017081.1.  
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To identify the relative evolutionary age of these ME-CDS, a sequence similarity search 
for the human ME-CDS to the genome sequences of the six species (chimp, rhesus, mouse, 
platypus and zebrafish) based on protein translation was performed. The distribution profiles of 
the conservation scores (the numbers of orthologous ME-CDS found within the 6 genomes 
examined) were compared among the ME classes. In this case, retrotransposon group was added 
to cover LTR, LINE, SINE, SVA.  As shown in Fig. 4, all ME classes, except for SVA, have 
ME-CDS spanning all 6 genomes, but the detailed distribution patterns depicted by the violin 
plots are different from each other. Overall, DNA transposons have relatively more cases with 
higher conservation scores compared to retrotransposons, which have more cases at the lower 
conservation scores. While the median values for these two groups are similar, DNA transposons 
have a much higher upper quartile and slimmer bottom part of the violin plot. This agrees with 
the relatively older age of DNA transposons compared to retrotransposons in these animal 
genomes. Within retrotransposons, the distribution pattern of conservations scores also seems to 
be indicative of the relative ages of ME classes with LINE being the oldest, SVA as the 
youngest, and SINE and LTR lying between. This overall pattern seems to agree with what we 
know since SVA is the youngest ME class seen only in chimp and human among the genomes 
included in this analysis, while LINE has existed throughout at least the evolution of mammals. 
SINEs seem to be older than LTRs, likely reflective of a possible very quick expansion of Alus 
during early primate evolution, while the rate of LTR integration might be more or less constant 
(Kazazian, 2004). These results indicate the participation of MEs in CDS is correlated with the 
timing of their emergence in the host genomes and many ME-CDS being highly conservative in 
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the evolution of primates, mammals and lower vertebrates. This indicates the importance of the 
genes involving ME-CDS (Appendix Fig. 2).   
 
Figure 4. Violin plots showing the degree of evolutionary conservation ME-CDS by ME 
type. The conservation score represents the number of species with the presence of the 
orthologous ME-CDS among 6 species including Pan troglodytes (Chimpanzee), Macaca 
mulatta (Rhesus monkey), Mus musculus (Mouse), Ornithorhynchus anatinus (Platypus), Gallus 
gallus (Chicken), Danio rerio (Zebrafish), in addition to human. “Retro” is for all 
retrotransposons (LINEs, SINEs, and SVAs). The violin plot shows the distribution of the 
conservation score.  The white dot represents the median and the thick black line represent the 
upper (50-75 percentile) and lower (< 50 percentile) quartile and thin black lines represent 
greater upper (> 75 percentile) quartile.  
 
We further examined the ratio of these ME-CDS as canonical transcripts and compared 
among different ME classes. The canonical transcript is the consensus transcript for a gene 
meeting a set of criteria as described in the method section.  Among the 4402 ME-CDS, 1201 
(27.3%) are part of the canonical transcripts for protein coding genes, and the remaining 3201 
(72.7%) ME-CDS belong to the alternative transcripts. For DNA- and LINE-derived ME-CDS, 
the ratio of being in the canonical transcripts is ~ 40% and is ~30% and ~15% for LTRs and 
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SINEs, respectively (Fig. 5). Very interestingly, SVAs, despite being very young, showed the 
highest ratio (~80%) for involving in canonical transcripts, and more specifically, 31 of the 40 
SVA-CDS are part of the canonical transcripts in human (Fig. 5).    
 
Figure 5. The ratios of ME-CDS in the canonical transcripts by ME class. The ratio is 
calculated by dividing the number of MEs in canonical transcripts by the total number of the 
same class MEs in the ME-transcriptome. There is a total of 4,402 MEs in CDS, among which 
1,201 MEs are part of canonical human transcripts. 
 
As a way of understanding the importance of these ME-CDS, we further examined the 
expression profiles among limited number human tissues based on publicly available RNA-seq 
data. As shown in the example of the heparan-alpha-glucosaminide N-acetyltransferase 
(HGSNAT) gene, the SVA-CDS transcript isoform, which involves a human-specific SVA, 
displayed a clear tissue-specific expression pattern. The expression of the SVA-CDS isoform 
was observed in some but not all tissues, and the ratio of SVA-CDS and overall HGSNAT 
expression levels also differ among the tissues expressing the SVA-CDS isoform (Fig. 6), 
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suggesting that these ME-CDS might play a role in cell differentiation and organism 
development.  
In summary, this indicates that the contribution of MEs to protein coding is not limited to 
alternative splicing variants, but with a large portion also being the major form of the transcripts 
for protein coding genes with SVAs being the most active participants of canonical transcripts, 
despite being the youngest class of MEs in the human genome.   
Among the MEs involved in the reference transcriptomes, we checked to see whether 
there is a bias in using certain ME regions. For this purpose, we surveyed the frequency of ME-
exon (mainly the ME-CDS) about the consensus sequence of each ME class and subclass for the 
major classes of MEs involved in the reference transcriptome based on the data provided in the 
RepeatMasker file (http://www.repeatmasker.org/). The percent occurrence of the consensus 
sequence used in ME-exons was calculated based on the number of times a particular sequence 
of the MEs was used. The percent of occurrence of the consensus sequences of ME-CDS and in 
the transcriptome excluding the CDS region was identified and compared against the same data 
for all MEs in the corresponding class or subclass present in the human genome (Fig. 7). It was 
determined that MEs in the transcriptome do not have a sequence preference when compared to 
their relative abundance in the genome except for SVA (Fig. 7). SVAs seem to have a higher 
sequence preference for the consensus regions between 600-1200 bp for involving in CDS (Fig 
7).  
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Figure 6. The expression profile of SVA-CDS form of the HGSNAT gene in comparison 
with the overall expression of the gene among human tissues. A) A screenshot of the UCSC 
genome browser showing the gene structure and ME composition of the HGSNAT gene. The 
SVA insertion is human specific based on the data in the conservation track; B) The overall 
expression of the HGSNAT gene was calculated using Cufflinks and the expression of SVA-
HGSNAT was calculated for ME-CDS using the fpkm calculation.  
 
43 
 
 
Figure 7. ME regional sequence usage in CDS and non-CDS transcriptomes. Line plots showing 
the consensus usage frequency for all MEs (red), MEs in CDS (black) and MEs in the 
transcriptome outside the CDS region (green). A) OldhAT1 (DNA transposon) B) SVAs; C) 
AluJ (SINE); D) L1P (LINE); E) THE1 (LTR).  
 
3.3 Functional contribution of MEs in proteins 
Among the CDS involving MEs, we wanted to find out how MEs impact the function of 
the proteins involved and whether there is any specific function associated with the MEs. For this 
purpose, we examined the presence of MEs in the conserved protein domains. As shown in 
Table 5, MEs contributed to a total of 1,244 conserved protein domains. Among the ME classes, 
SINEs contribute the most number of sequences to conserved domains, followed by DNA, LINE, 
LTR and SVA. Interestingly, both SINE and SVAs are part of GVQW binding domains, which is 
a short domain that is often part of larger domains with the function to be known (Marchler-
Bauer, et al., 2007). Interestingly, SVAs, being the youngest mobile elements with a relatively 
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small number of members, also contribute to conserved protein domains. In addition, LTR 
contributes to a PNMA protein domain, which has so far only been studied in mammals and 
shown to be associated with neurological disorders (Dalmau, et al., 1999; Schüller, et al., 2005). 
Majority of the DNA transposons in the protein coding region have the DDE_1 conserved 
binding domain. This domain is a member of the DDE superfamily, which contains three 
carboxylate residues that are believed to be responsible for coordinating metal ions needed for 
catalysis (Marchler-Bauer, et al., 2007). LINEs have conserved domains that belong to the 
DUF1725, which has been annotated as being putative L1 retrotransposons or LINE-1 reverse 
transcriptase homologs. These results show the role of MEs by contributing to the conserved 
domains of proteins.  
An analysis of gene ontology terms was performed for genes involving ME-CDS to see 
whether they have any enrichment for certain biological functions. As show in Table 6, using the 
DAVID tools, it was observed that the molecular function of “ATP binding”, “metal-ion 
binding”, and “protein-binding” are statistically over-represented among these genes containing 
ME-CDS. ATP-binding seems to be commonly seen, being over-presented among ME-CDS for 
DNA and LINE. Metal ion-binding is shown to be over-represented among LTR and SINE CDS 
genes. While protein-binding and metal ion binding was shown over-represented among SINE-
CDS genes No over-representation of GO terms was seen for SVA-CDS genes, likely due to the 
small numbers of genes (40).  
These results indicated that MEs contribute to conserved protein regions, implying the 
functional importance. It seems that these ME-protein domains contribute to specific types of 
molecular function, including binding of ATP, metal ions, and proteins, with ATP-binding being 
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most often seen. The specific mechanisms and related biological significance of these ME-CDS 
in proteins remain to be examined in future studies. 
Table 5. Contribution of MEs subfamily to conserved domains.   
ME Class 
Total ME-
CDS 
Total 
Number of 
Domains 
Ratio of 
domains to ME 
total Count 
Top Conserved 
domains in ME-
CDS 
# of top Conserved 
domains 
DNA 484 151 0.31 DDE_1 6 
LTR 529 38 0.07 PNMA 14 
LINE 1233 110 0.09 DUF1725 5 
SINE 2116 941 0.44 GVQW 921 
SVA 40 4 0.10 GVQW 3 
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Table 6. Significantly over-represented gene ontologies of molecular function among genes 
containing ME-CDS using DAVID functional tool 
ME Class Gene ontology term  
% involved 
gene P-Value 
Benjamini corrected  
P-value 
DNA ATP binding 13.3 3.1E-06 2.4E-02 
LTR metal ion binding 15.2 3.1E-04 8.4E-02 
LINE ATP binding 11.1 1.3E -05 1.3E-02 
SINE 
protein binding 49.5 1.8E-06 1.2E-03 
metal ion binding 13.7 5.1E-6 2.4E-3 
 
 
3.4 MEs play a role in post-transcriptional regulation  
Since gene expression can be regulated also post-transcriptionally, for example, via 
miRNA to regulate the stability of mRNAs by targeting at the 3’-UTR regions (Pedersen and 
Zisoulis, 2016), we are interested in knowing how much MEs contribute to miRNA target sites 
in the mRNAs, and whether MEs also contrite to the generation of miRNA. To answer these 
questions, we identified 1,881 and 2,813 primary and mature human miRNA, respectively, using 
the miRbase 21 database (Kozomara and Griffiths-Jones, 2014).  A position overlap was 
performed with all known MEs in the human genome. As shown in Table 7, MEs contribute 
26.9% (507/ 1881) and 16.9 % (477/2813) of primary and mature miRNA sequences. Among 
these, a significant portion of the primary (148/507) and mature miRNA (178/477) are 
contributed by DNA transposons. SINEs and LINEs contribute to slightly less but very close 
number of primary miRNA (146 and 144, respectively) and mature miRNAs (130 and 113, 
respectively), whereas LTR elements contribute 69 and 56 primary and mature miRNAs, 
respectively. By sequence length, MEs contribute 16% (24.9 Kbp/152 Kbp) and 15.5% (8.9/57 
Kbp) of the primary and mature miRNAs, respectively. DNA transposons contribute the most by 
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length, followed by LINE, SINE, LTR. SVAs being the youngest MEs does not contribute to 
miRNA sequences.  
For identifying MEs’ contribution to miRNA target sites, we used Tarbase, which is a 
database that has computationally identified 28nt miRNA target sites (Paraskevopoulou, et al., 
2013). As shown in Table 8, there were a total of 6,269,146 human miRNA target sites 
identified in the 3’-UTR, among which a total of 569,707 miRNA target sites overlapped with 
MEs. Thus, MEs contribute ~9% of the miRNA target sites, and these MEs represent ~56% of all 
MEs located in the 3’-UTR, representing a total of 16,881 unique MEs. Among these miRNA 
MEs, SINEs contribute to the most number of miRNA target sites followed by LINE, DNA, LTR 
and SVA. Conversely, looking at percentage MEs in the 3’-UTR contributing to miRNA target 
sites, 60% of DNA transposons contribute to miRNA target sites, followed by SINE (57%), 
LINE (55%), LTR (52%), SVA (44%) (Table 8). This indicates that 56.6% of the MEs in the 3’-
UTR contribute to miRNA target sites, and collectively, MEs contribute to 9% 
(569,707/6,269,146) of all miRNA target sites (Table 8).  
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Table 7.  Contribution of MEs to primary and mature miRNA sequences.  
ME 
Class 
*ME-
primary 
miRNA 
(count) 
ME-
primary 
miRNA 
length 
(Kbp) 
*ME-
mature 
miRNA 
sequences 
(count) 
ME-
mature 
miRNA 
length 
(Kbp) 
**% 
Contribution to 
primary 
miRNAs 
**% 
Contribution to 
mature miRNAs 
DNA 148 9.7 178 3.6 6.4 6.1 
LTR 69 3.3 56 1.1 2.2 1.9 
LINE 146 6.0 130 2.3 4.0 4.0 
SINE 144 5.9 113 1.9 3.9 3.4 
All 507 24.9 477 8.9 16.4 15.5 
* There a total of 1,881 primary miRNA sequences in the human transcriptome, out of which MEs 
contribute to 507 primary miRNAs. There are a total of 2,813 mature miRNA transcripts and MEs 
contribute 477 mature miRNAs; 
**The percent contribution for the primary is calculated based on the ME-primary miRNA length divided 
by total primary miRNA length and percent contribution of mature miRNA is calculate based on ME-
mature miRNA length divided by mature miRNA length. The total primary miRNA length in the 
transcriptome is 152Kbp and mature miRNA is 57Kbp in length. 
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Table 8. The contribution of MEs to miRNA target sites.  
*%ME in miRNA target site calculated based on Unique ME-miRNA target sites divided by MEs in 3’-
UTR e.g. for DNA transposons it is (2,555/4,271) *100 = 59.8%; 
** %total miRNA sites calculated by ME-miRNA target sites divided by the total number miRNA target 
sites in the 3’-UTR e.g. for DNA transposons, it is (69,343/6,269,146) *100 = 1.1%. There are a total of 
6,269,146 miRNA target sites identified in the human transcriptome. 
 
RNA editing is a mechanism through which transcripts are silenced and inhibited from 
being translated into protein (Chen, et al., 2008). RNA editing occurs in the 3’-UTR region when 
double stranded RNA structures are formed due to a pair of inverted repetitive elements (Chen 
and Carmichael, 2008) (Athanasiadis, et al., 2004). Therefore, we examined the contribution of 
MEs to dsRNA. Using the RNA fold program (Lorenz, et al., 2011), a total of 2,921 dsRNA sites 
that are formed by inverted MEs in 3’-UTR were identified. These dsRNA sites are associated 
with 1,539 transcripts derived from 1,301 genes (Table 9). Inverted Repeats occur when two 
MEs are inserted in the opposite orientation to each other. Inverted Repeat Alus (IRAlu) 
(1891/2921) are the most represented Inverted MEs (IRME). This indicates that IRAlu in the 3’-
UTR regions is predominantly folded into dsRNA. This is likely since Alu elements share ~70% 
ME Class 
ME-miRNA 
target sites  
Unique 
MEs-
miRNA 
target sites 
MEs in 
3’-UTR 
*%ME in 
miRNA target 
sites   
% total ME-
miRNA  
 
*% to total 
miRNA sites 
 
DNA 69,343 2,555 4,271 59.8 12.2 1.1 
LTR 60,394 1,533 2,906 52.8 10.6 0.9 
LINE 165,718 4,359 7,879 55.3 29.1 2.6 
SINE 273,617 8,417 14,713 57.2 48.0 4.3 
SVA 635 17 38 44.7 0.1 0.01 
Total 569,707 16,881 29,807 56.6 100.0 9.1 
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of their sequences to each other (Elbarbary, et al., 2013).  For example, Glutathione-Disulfide 
Reductase (GSR) gene transcript has a dsRNA structure because of IRAlu in the 3’-UTR regions 
(Fig. 8). Gene ontology term enrichment analysis for genes involving ME-dsRNA showed that 
transcription factor was a highly over-represented term, indicating that genes that contain IRMEs 
might be involved in transcription regulation (Table 10).   
Table 9. The contribution of MEs to dsRNA in the 3’-UTR regions.  
Inverted Repeat (IR) 
type 
# IR % as IR 
ME in 3’-UTR % 3’-UTR ME 
as IRME 
IRAlu 1891 64.7 9,718 19.5 
IRLINE 112 3.8 7,879 1.4 
IROther 918 31.4 12,210 7.5 
Total 2921 100.0 29,807 9.8 
 
Table 10. Enrichment analysis for gene ontology (GO) terms of biological processes for 
genes containing MEs with the potential to form double stranded RNA  
  
 
 
 
 
 
GO terms for biological processes Genes P-value 
Benjamini 
corrected P-value 
Transcription 175 7.80E-05 1.80E-01 
Regulation of transcription 150 1.50E-04 1.70E-01 
Regulation of RNA metabolic process 152 2.00E-04 1.50E-01 
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Figure 8. dsRNA structure in the 3’UTR transcript for the GSR gene. A) A screenshot of the 
UCSC genome browser showing the 3’-UTR of the transcript for the GSR gene on chromosome 
8. The two Alu elements are in opposite orientation (indicated by the two red circle); B) A 
dsRNA structure is predicted to exist for the GSR transcript involving the AluJb (311 nt) and 
antisense AluSp (307 nt) (indicated by the one red circle).  
 
3.5 Transcriptional activity of MEs in all human transcriptomes: MEs are expressed in all 
tissues in humans   
All prior analyses have been based on the reference transcriptome, which ignores most of 
the non-coding transcripts from the repetitive regions of the genome. Therefore, a lot of the 
transcripts for MEs are not covered. To obtain a more comprehensive picture of the MEs’ 
contribution to the transcriptomes in human tissues, we surveyed the transcriptomes of human 
tissues based on RNA-seq data. As shown in Table 11, among the 23 human tissues examined, 
MEs on average contribute to ~24% of the transcriptome ranging from 19.2% in skeletal muscle 
to 31.4% in the pancreas. Among these, the ME portion of the transcriptomes, on average, has 
~5% ME-transcriptome outside of the reference transcriptome, and this portion ranges from 
3.7% in Stomach to 9.2% in testis. Each tissue has a different total transcriptome length and this 
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might be due to the unique number of expressed genes in each tissue. Interestingly, MEs 
contribute to a slightly higher percentage of the transcriptomes in testis, liver, fetal colon, and 
pancreas. Furthermore, among the ME types, SINEs are highly represented and contribute to 
~47% of ME-portion of the transcriptomes, followed by LINE, LTR, DNA, and SVA. This 
pattern is roughly similar among most tissues (Fig. 9). However, in the pancreas, colon and fetal 
colon, and white blood cells (WBC) a different pattern is observed with LINEs contributing 
more than SINEs (Fig. 9). In WBC, LINEs contribute to 47% to the ME-transcriptome. For 
tissues with the fetal and adult samples available, the ME proportion in transcriptome is higher in 
fetal tissues than for the adult tissue for ovary and colon. However, in testis the percentage of 
MEs is varies in fetal and adult testis, suggesting that not only the relative expression of MEs 
varies across different tissues, but also across different developmental stages. 
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Table 11. Contribution of MEs to the transcriptome of various human tissues 
Tissue 
Non-redundant 
Length (Mbp) 
ME Non-
redundant 
length (Mbp) 
Contribution ME 
to Transcriptome 
(%) 
ME Non-redundant 
length Intergenic 
Region (Mbp) 
Contribution of 
ME to Intergenic 
Region (%) 
Adipose 188.9 41.9 22.2 10.7 5.6 
Adrenal 362.1 80.9 22.3 19.7 5.4 
Brain* 579.5 145 25 37.7 6.5 
Breast 240.2 53.9 22.5 13.8 5.8 
Fetal Colon* 1257.2 367.9 29.3 63.4 5.0 
Colon* 784.4 194.7 24.8 30.0 3.8 
Heart* 560.1 146 26.1 27.3 4.9 
Kidney* 285.5 68.5 24 17.3 6.1 
Liver* 417 113.9 27.3 22.7 5.5 
Lung* 184.6 42.5 23 9.6 5.2 
Lymph node 160.2 35.1 21.9 9.9 6.2 
Lymphocyte 282.8 57.8 20.4 11.5 4.1 
Fetal Ovary* 775.2 189.1 24.4 39.9 5.2 
Ovary 314.2 69.3 22 17.5 5.6 
Pancreas* 1421 446.9 31.4 87.1 6.1 
Prostate 165.4 34.2 20.7 9.3 5.6 
Skeletal Muscle 74.2 14.3 19.2 4.5 6.0 
Stomach* 879.5 239.5 27.2 32.6 3.7 
Fetal Testis* 502.9 118.2 23.5 24.0 4.8 
Testis * 1147.9 327.4 28.5 105.8 9.2 
Thymus* 788.4 193.3 24.5 23.5 3.0 
Thyroid 245 54.5 22.2 14.3 5.8 
WBC 99.6 22.6 22.7 7.1 7.1 
Average 531.7 139.7 24.1 27.8 5.2 
 * Tissues have multiple RNA-seq samples and their sequences have been merged.  
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Figure 9. Contribution by MEs class across various human tissues. Represents the Non -
redundant length of MEs contribution by length to the transcriptome of each tissue. *Tissues 
have multiple RNA-seq samples and their sequences have been merged. 
Further, we also examined the pattern of ME expression in these tissues. As shown in the 
boxplots in Fig. 10, MEs are expressed in all tissues, and they are expressed at a wide range of 
expression levels with the fpkm values of individual MEs ranging from a 0 to a maximum of 
215.4. The pattern of ME expression seemed to be quite variable in the same tissue across 
different individuals. For example, the pattern of ME expression in boxplot style varies among 
the brain and testis tissues from different individuals (Fig. 11), suggesting a highly dynamic 
nature reflective of the specific cellular environment in individuals.   
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Figure 10. Boxplot expression (fpkm (log2)) of all MEs in the chromosome 2 in various 
tissues. Boxplot represents the spread of fpkm values in each tissue. *Represents tissues that 
have multiple SRA ID. Listed are SRA ID used for visualization. Brain SRR2040575, Fetal 
Colon SRR2014228, Colon ERR030884, Heart SRR2040577, Kidney ERR030885, Liver 
SRR2040579, Lung ERR030879, Fetal Ovary SRR1654908, Pancreas SRR1299345, Stomach 
SRR2014241, Fetal Testis SRR1654916, Testis SRR2040583, Thymus SRR1299439.  
lo
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Figure 11. Boxplots showing the expression (fpkm (log2)) of MEs in the chromosome 2 across 
multiple samples of the Testis, Brain and Heart Tissue samples.  
 
To gain a better understanding of the driving force for ME expression, we tried to 
separate the MEs in the intergenic regions from those within a gene, as the latter could have the 
expression driven by the host gene, while those in intergenic are likely to expressed 
autonomously using their own promoters. For this purpose, we compared the population of MEs 
that are expressed in genic and intergenic regions in brain, testis, and adipose for each type of 
MEs. As seen in Fig. 12 & 13, all types of MEs are expressed in both regions. However, true for 
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all tissues and for all ME types, MEs in genic regions have a higher proportion being expressed 
than those in intergenic regions, suggesting that MEs in intergenic are more likely to be 
suppressed for expression, while the higher chance of being expressed in genic regions could be 
due to passive expression is driven by the host genes. Among the three tissues examined, testis 
seems to have the highest proportion of MEs being expressed in both the genic and intergenic 
regions, while adipose has the lowest among the three for both regions. This agrees with the fact 
that testis has the largest number of expressed genes and it is known that testis is subjected to a 
lower level of DNA methylation, which in general suppresses the gene expression. In this sense, 
adipose, as a highly differentiated and specialized tissue, may have a limited number of 
expressed genes and have most of the genome suppressed for gene expression via some sort of 
epigenetic mechanism. Among different types of MEs, SVAs seem to have the highest portion 
being expressed in both regions for tissues examined, while the other ME types seem to have a 
similar pattern with SINE showing slightly higher expression than DNA, LTR, and LINE (Fig. 
12).  
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Figure 12. The percentages of MEs expressed and not expressed in the intergenic and 
transcript region. Intergenic region is 1000 bp away from the annotated transcript. Expression 
of 2,172,495 MEs in the human genome were analyzed for each tissue.  Transcript region is 
defined as the region that is annotated by GENCODE and RefSeq and excludes the intronic and 
promoter region. A) Brain samples (SRR2040575); B) Testis samples (SRR2040581); C) 
Adipose samples (ERR030880).   
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Figure 13. Expression of MEs in the intergenic and transcript regions. A) Brain samples 
(SRR2040575); B) Testis Samples (SRR2040581); C) Adipose samples (ERR030880). 
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Chapter 4 Discussions  
The main objective of this study was to systematically analyze the contribution of MEs in 
the human transcriptomes as part of a bigger question regarding the role of MEs in the genome. 
From this study, it was shown that MEs are present in the human transcriptomes, contributing 
16% to the reference transcriptome and at least 19% of the transcriptomes of all tissues with their 
presence not only in non-coding transcripts but also in protein-coding transcripts. For protein 
coding transcripts, the contribution of MEs is not limited to the untranslated regions but includes 
also the protein-coding sequences. Furthermore, such involvement applies not only to alternative 
splice forms, but also to canonical forms for many genes (Table 2 & 3).  
While all classes of MEs participate in all exonic regions, SINEs contribute the most to 
the transcriptomes, followed by LINEs, LTRs and SVAs (Table 4). Interestingly, SVAs as the 
most recent ME class in the human genome showed the highest ratio of participation to the 
human reference transcriptome when normalized against relative amount of SVAs in the genome 
(Fig. 2). Further, our data showed that MEs participate in the post-transcriptional regulation of 
genes by contributing to the miRNA generation, miRNA target sites, and the Inverted Repeats as 
RNA editing targets. In sections below, we discuss the relevance of our results in details. 
4.1 MEs in functional domains 
 Interestingly, not only are MEs expressed in the exonic regions in non-coding transcripts 
and the untranslated regions of protein coding genes but are also present in the protein coding 
regions (Fig. 2). Through this study, the functional impact of MEs involved in the functional 
domain of proteins was analyzed. Out data showed that MEs have contributed to the protein 
coding regions that are conserved across a long evolutionary span from zebrafish to human or in 
mammals or throughout the primate evolution (Fig. 4). It has been speculated that ancient MEs 
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provide sequences for host proteins and may have a role in important biological processes. An 
known example of MEs playing an evolutionary role is a DNA transposon that is a source of 
RAG1 and RAG2 proteins that carry out VDJ recombination of immunoglobulin genes in all 
vertebrates (Fugmann, 2010). Our data revealed that SINEs and SVAs contribute to a GVWQ 
conserved domain with unknown function (Table 5). SVAs are considered repeats of repeats and 
have a portion of Alu in their sequences and it is likely that the Alu portion in SVAs is 
contributing to the GVQ functional domain. In addition, gene ontology term enrichment analysis 
for all ME-CDS regions showed that ATP-binding proteins are enriched among those with ME-
CDS, whereas metal ion binding domains are enriched among LTR-CDS (Table 6).  
4.2 Role of ME in the non-coding region 
MEs have a preference to non-coding region for their participation in transcriptome and 
we observe that 29.1% of MEs are in non-coding region vs 9.9% of MEs in the protein coding 
genes (Table 2). We further looked at the breakdown of MEs in the protein coding region and 
we observe that ME contribute to 1.1% to CDS region and 17% to the 5’-UTR and 10.0 to the 
3’-UTR (Table 3). The non-coding region represents the largest part of the transcriptome and 
has the most number of MEs inserted in that region (Table 3). Non-coding regions are emerging 
as important regulators of gene expression associated with important biological functions 
(Prensner and Chinnaiyan, 2011; Ulitsky and Bartel, 2013). For instance, Fort et al., identified 
2,372 LTR-associated non-coding RNAs, many of which appeared to have originated from LTR 
in a stem cell line. Knocking out four of the LTR-based non-coding RNAs affected stem cell 
status (Fort, et al., 2014). Furthermore, MEs substantially contribute to the evolution of 
noncoding region (Johnson and Guigó, 2014). miRNAs are part of non-coding region and 
previous studies have shown that MEs have played a role in the generation in miRNA 
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(Paraskevopoulou, et al., 2013; Pedersen and Zisoulis, 2016; Roberts, et al., 2014). Primary 
miRNAs are a stem-loop structure that are transcribed in the nucleus and then transported into 
cytoplasm and made into mature miRNAs (Ambros, 2004). It has been hypothesized that some 
miRNA was initially created by two similar MEs being inserted in the same genomic locus and 
this results in MEs forming complementary base pairs and subsequently becoming part of RNAi 
pathway (Paraskevopoulou, et al., 2013; Roberts, et al., 2014). Our data showed that a large 
portion of miRNA sequences both at the primary and mature miRNA levels were contributed by 
MEs (Table 7). Our data also seem to support the notion that evolutionary older MEs have 
contributed to the generation of miRNA sequences (Roberts, et al., 2014) with DNA transposons 
contributing to the largest portion to miRNA followed by LINEs and SINEs, whereas SVAs as 
the youngest ME class in the human genome have not been seen in participation of miRNAs. 
However, SVAs may participate in future miRNA biogenesis, since SVAs tend to insert into 
existing SVAs and new miRNA are likely to be generated when two similar MEs are inserted in 
the same locus. Currently, miRNA annotation is biased towards non-repetitive sequences and 
future research may reveal more new miRNA sequences involving MEs. Taken together, non-
coding RNAs play an important role in gene regulation and MEs may have contributed to the 
origin of many of these non-coding RNAs. 
4.3 Contribution of SVAs to the human transcriptome  
SVA are the most recent evolutionary ME class in the human genome and have been 
present only in the hominin genomes with only 2700 copies, constituting 0.2% of the human 
genome (Cordaux and Batzer, 2009; Wang, et al., 2005). Despite making the smallest 
contribution to transcriptome by sequence length due to their small copy number in the human 
genome, our data showed that SVA have the highest ratio of participation in contributing to CDS 
when normalized against the amount of SVAs in the genome (0.28% for SVAs vs. 0.06% for 
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DNA as the 2nd highest) (Fig. 2C). Furthermore, while other classes of MEs are more involved in 
alternative transcripts, SVAs showed the highest percentage in canonical transcripts among the 
ME classes (Fig. 6). SVAs’ very active participation in transcriptome might be attributed at least 
in part to their preferential insertions into genic regions (Wang, et al., 2006). Furthermore, 
alternative splice forms contributed by SVAs, might be related to development and 
differentiation of tissues. In the example of HSGNAT gene, an SVA contributed to an alternative 
transcript that demonstrated a tissue-specific expression pattern, suggestive of a role in tissue-
differentiation (Fig. 6). Future studies can examine SVAs that are insertional polymorphic in the 
exon regions, especially in the coding regions, as such polymorphisms are likely to have a 
functional impact, which may contribute to phenotypic differences among individuals and 
populations. Being present only in the hominid primates and most active in the human genome, 
it’s reasonable to believe that SVAs have contributed to genetic versatility and resulted in 
changes in the human genome that are not seen in other primate species.   
4.4 MEs in alternative transcripts 
Alternative splicing is known to be a mechanism used by organisms, especially higher 
organisms, to increase the complexity of the transcriptomes and proteomes using a limited gene 
pool. Alternative mRNA splice forms can encode proteins with different functions and can be 
differentially regulated (Black, 2000).While humans have a similar number of genes to 
nematodes, humans have a much larger number of transcripts and protein products resulted 
mainly from alternative splicing. Ninety-five percent of the human genes are alternatively 
spliced, whereas 25% of genes in nematodes are alternatively spliced (Abascal, et al., 2015). Our 
data showed that MEs are a major contributor for alternative splicing in humans as illustrated by 
examples in Fig. 1. Among the ME classes, SINEs (Alus) have the highest ratio (85%) as well as 
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the absolute number contributing to alternative transcripts (Fig. 5). This seems to suggest that 
Alus in the constitutive splice sites were most likely selected against, whereas Alu sequences in 
the alternative splice sites were preferred (Chen, et al., 2008; Deininger, 2011). It might be 
related to the fact that Alu sequences contain weak splice sites and their involvements are likely 
to be in alternative transcripts (Deininger, 2011).  
As shown in the example of HGSNAT gene Fig. 6, ME-alternative transcripts can be 
associated with tissue-specific expression, suggesting they may partially contribute to cell 
differentiation and development via diversification of transcriptomes among cell types. 
Furthermore, in this case, this SVA-derived HGSNAT isoform alternative transcript is human 
specific, and this implies that the function of the transcript is also human specific. With most of 
the MEs being lineage- or species-specific, they can contribute to transcriptome differences 
associated with the evolution of lineages and species.     
4.5 The role of MEs in post-transcriptional regulation 
In the past, it has been shown that MEs inserted in the opposite orientation can create 
dsRNA structures in the 3’-UTR that are edited through the ADAR editing pathway. ADAR 
editing is a mechanism through which adenosine is changed to Iosine and causes the transcript to 
be retained in the nucleus or not translated into protein (Hundley and Bass, 2010). Editing 
depends on RNA fold-back structures formed between intramolecular IRME. It’s been shown 
that IRME is created by the formation of dsRNA play a role in human pre-mRNAs (Chen, et al., 
2008) (Athanasiadis, et al., 2004). In addition, hyper-edited Iosine containing RNAs are retained 
in the nucleus by a protein complex. Through our analysis, 1,539 transcripts were identified to 
carry IRME, among which Inverted Repeat Alu (IRAlu) are the most represented in terms of 
both absolute number and the ratio (19%) (Table 9). This is likely due to Alus’ relative short 
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length and the relatively higher sequence similarity among each other (~70%) due to their 
relatively young age. A gene ontology (GO) term enrichment analysis was performed on genes 
carrying IRME (Table 10), and it was observed that these genes are enriched for function in the 
regulation of transcription and transcriptional activity. This result suggests that MEs participate 
in post-transcriptional regulation via IRME, which may preferentially target genes involved in 
transcription regulation. Alus as major contributor to ADAR editing and being unique to 
primates may suggest that Alus provide primates a unique mechanism of gene regulation not 
available in non-primate species. 
4.6 Contribution of MEs to the full transcriptomes of human tissues  
The reference transcriptome we used in this study represents a static non-redundant 
collection of all annotated transcripts found for humans. It does not reflect the full transcriptome 
of any given cell or tissue because most expressed MEs not associated with known genes are not 
included in the reference set. In addition, the reference transcriptome lacks the quantification 
information of the transcripts. To get a sense of MEs’ contribution in the full transcriptomes of 
human tissues and the variation among tissues, we surveyed the full transcriptomes of various 
human tissues based on publicly available RNA-seq data. Our data showed that MEs contribute 
on average 5% of the transcriptome outside of the reference transcriptome, and among the 23 
tissues analyzed, this portion ranges from 3.7% in stomach to 9.2% in testis (Table 11). The total 
contribution of MEs to these tissue transcriptomes by expressed sequence length ranged from 
19% in skeletal muscle to 31% in pancreas, averaging ~24%, with certain differentiated tissues 
(testis, pancreas, and liver) on the higher end (30%) of the spectrum (Table 11).  
The expression of MEs may be driven by two kinds of mechanisms. One is the passive 
expression driven by the host genes, which may also apply to MEs residing in the intron regions 
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in addition to the exon regions. While some of these MEs may still be driven by their own 
promoter to express, a lot of them could be expressed as part of transcripts of the host genes, i.e. 
the lariat-introns surviving the degradation (Hesselberth, 2013). Our data showed that ME 
expression is highly variable across tissues with higher expression seen in testis, ovary, fetal 
colon, liver than in other tissues (Table 11). Such tissue differential expression of MEs might be 
related to the differential level of DNA methylation in the tissues. It has been speculated MEs are 
silenced through DNA methylation (Chalitchagorn, et al., 2004). In cells under cellular stress or 
tumorigenesis, it has been shown that there is global suppression of DNA methylation or 
chromatin modification which leads to increased expression of MEs (Chalitchagorn, et al., 2004; 
Shen, et al., 2007). In germline tissue, there is lower DNA methylation, and this allows MEs to 
be expressed at higher levels compared to other tissues. In addition, testis and ovary are immune 
privileged sites and expression of their genes in somatic tissues can trigger an autoimmune 
response (Shen, et al., 2007). Therefore, a mechanism to maintain silencing in somatic tissues is 
required. which results in lower expression of genes in MEs in the transcriptome (Shen, et al., 
2007). It has also been suggested that as age increases, the expression of MEs increases since 
there is a relaxation of heterochromatic regions (De Cecco, et al., 2013). However, age-related 
information is not available for all RNA-seq tissue samples.  
Expression of MEs in a tissue specific manner gives rise to a unique transcriptome (Fig. 
10), and this might lead future researchers to understanding tissue specific behaviour.  While 
SINEs were the most prevalently expressed ME class in most tissues followed by LINE, LTR, 
DNA and SVA (Fig. 9), whereas in certain tissues (WBC, pancreas and colon), LINEs were the 
most prevalently expressed ME class (Fig. 9). Such differences in ME composition may indicate 
the existence of tissue and individual specific regulation, which leads to lower or higher 
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expression of certain classes of MEs in different tissues (Fig. 11). Further studies on different 
populations and tissues will help identify population and tissue specific variation of ME 
expression.  
Among the ME classes, LINEs have been shown to contribute to cell differentiation by 
active retrotransposition during neurogenesis (birth of new neurons) (Erwin, et al., 2014). Neural 
stems are multipotent and reside in the neurogenic region of the brain. They have the ability to 
differentiate into glial progenitors or neural progenitors (Muotri, 2016). LINEs can aid in the 
differentiation of neural cells by active retrotransposition (Erwin, et al., 2014). In neural stem 
cells LINEs are repressed by DNA methylation and as neural cells transition into progenitor cells 
LINEs are demethylated. Once LINEs are demethylated, WNT transcription factors activate 
LINEs transcription and this results in increased transcription and retrotransposition. LINEs 
contain binding sites for WNT signaling pathway transcription factors and these transcription 
factors are known to be involved in neurogenesis (Kuwabara, et al., 2009). Further active 
somatic retrotransposition leads to differences among somatic cells (i.e., the phenomenon of 
chimeric genomes), which in turn leads to distinct transcriptomes by altering nearby gene 
expression (Erwin, et al., 2014).  
Interestingly, our study has shown that MEs in the intergenic region are being expressed 
(Fig. 12 & 13). Unlike MEs residing inside genes, which are mostly passively expressed as part 
of the gene transcripts, these MEs are likely actively transcribed using their own promoters. 
These intergenic MEs might participate the regulatory pathways or directly alter the expression 
of neighbouring genes. They can function in both the nucleus and the cytoplasm through various 
mechanisms and can interact with transcription factors, suggest that actively transcribed MEs 
play certain roles in cells (Kino, et al., 2010; Rinn, et al., 2007). Also, it has been hypothesized 
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that two juxtaposing ME inserted opposite orientation to each other can result in the formation of 
novel miRNA (Chen, et al., 2008). It is possible for MEs in the intergenic regions to be involved 
in the generation of new miRNA.  
In summary, our data show that in addition to the reference transcriptome, MEs in the 
intergenic regions seem to be widely expressed, and their expression profiles seem to be tissue 
specific and individually specific. By participating in various cellular regulation, these 
differentially expressed MEs might contribute in a certain degree to cell differentiation and 
differences among different cells in the same individuals, and the same type of cells in different 
individuals and same tissues across different stages of one individual’s life-span.  
4.7 Summary and Conclusions  
In this study, through an unprecedented systematic survey of MEs in the reference 
transcriptome as well as the complete transcriptomes of many human tissues, we have 
demonstrated that MEs make significant contribution to human transcriptomes. Specifically, 
MEs contribute to ~16% of the reference transcriptome and on average ~24% of the full 
transcriptomes in human tissues. All classes of MEs participate in all types of exon features with 
the majority in the non-coding transcript or untranslated regions of protein coding transcripts. 
However, MEs also contribute to protein coding sequences that have a range of evolutionary 
conservation among vertebrate, mammalian and primate evolution. MEs also contribute to 
conserved protein domains with specific type of molecular functions. Interestingly and very 
unexpectedly, SVAs, as an evolutionary very young ME class, is shown to have already made an 
active contribution to the protein coding regions of genes, with the majority involved in 
canonical transcripts. Furthermore, MEs participate in post-transcriptional regulation via 
generation of miRNAs, contributing miRNA target sites, forming inverted IR sequences for 
RNA-editing.  
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From our data, we conclude that MEs are active participants in human transcriptomes and 
post-transcriptional regulation, with much of these seem to be contributing to the evolution of 
mammals and primates via generation of new protein coding capacity and regulatory 
mechanisms. Future studies focusing on elucidating the function of specific ME-exons and ME-
derived post-transcriptional regulation as well as the role of lineage- and species-specific MEs in 
speciation would shed further lights for better understanding the functions of MEs in genome 
evolution and gene function. 
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Appendix 
 
Table 1. Types of Genes in the reference transcriptome 
Non-Coding Transcript Biotypes  Count of Genes  
3prime_overlapping_ncrna 29 
antisense 5560 
genes unique to RefSeq 1848 
IG_C_gene 14 
IG_C_pseudogene 9 
IG_D_gene 37 
IG_J_gene 18 
IG_J_pseudogene 3 
IG_V_gene 147 
IG_V_pseudogene 181 
lincRNA 7669 
macro_lncRNA 1 
miRNA 4081 
misc_RNA 2289 
Mt_rRNA 2 
Mt_tRNA 22 
polymorphic_pseudogene 57 
processed_transcript 496 
protein_coding 19768 
pseudogene 20 
ribozyme 6 
rRNA 543 
scaRNA 48 
sense_intronic 915 
sense_overlapping 194 
snoRNA 943 
snRNA 1895 
sRNA 20 
TEC 1050 
TR_C_gene 6 
TR_D_gene 4 
TR_J_gene 79 
TR_J_pseudogene 4 
TR_V_gene 106 
TR_V_pseudogene 30 
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transcribed_processed_pseudogene 441 
transcribed_unitary_pseudogene 2 
transcribed_unprocessed_pseudogene 665 
translated_unprocessed_pseudogene 1 
vaultRNA 1 
Total Number of Genes 49204 
 
Table 2. RNA-seq tissue and Experiment IDs used in this study 
Tissue Experiment ID Tissue Experiment ID Tissue Experiment ID 
Adipose ERR030880 Liver SRR2040580 Pancreas SRR1299341 
Adrenal ERR030881 Lung ERR030879 Pancreas SRR1654904 
Brain ERR030882 Lung SRR2103637 Pancreas SRR1654905 
Brain SRR2040575 Lung SRR2103638 Pancreas SRR1299327 
Brain SRR2040576 Lymph Node ERR030878 Pancreas SRR1299328 
Breast ERR030883 Lymphocyte  SRR954235 Pancreas SRR1299329 
Colon ERR030884 Ovary ERR030874 Pancreas SRR1299330 
Colon SRR2012208 Pancreas SRR1299331 Pancreas SRR1299331 
Colon SRR2012209 Pancreas SRR1299335 Pancreas SRR1299335 
Fetal Colon SRR2012627 Pancreas SRR1299336 Pancreas SRR1299336 
Fetal Colon SRR2014228 Pancreas SRR1299337 Pancreas SRR1299337 
Fetal Ovary SRR1654906 Pancreas SRR1299341 Pancreas SRR1299341 
Fetal Ovary SRR1654907 Pancreas SRR1299342 Prostate ERR030877 
Fetal Ovary SRR1654908 Pancreas SRR1299343 Skeletal muscle ERR030876 
Fetal Ovary SRR1654915 Pancreas SRR1299344 Stomach SRR2014241 
Fetal Ovary SRR1654916 Pancreas SRR1299345 Stomach SRR2014242 
Fetal Ovary SRR1654903 Pancreas SRR1299320 Stomach SRR2014243 
Fetal Testis SRR1654909 Pancreas SRR1299321 Stomach SRR2014244 
Fetal Testis SRR1654910 Pancreas SRR1299322 Stomach SRR2014245 
Fetal Testis SRR1654913 Pancreas SRR1299324 Testis ERR030873 
Fetal Testis SRR1654914 Pancreas SRR1299325 Testis SRR2040581 
Heart ERR030886 Pancreas SRR1299327 Testis SRR2040582 
Heart SRR2040577 Pancreas SRR1299328 Testis SRR2040583 
Heart SRR2040578 Pancreas SRR1299329 Thymus SRR1299439 
Kidney ERR030885 Pancreas SRR1299330 Thymus SRR1299440 
Kidney SRR1536710 Pancreas SRR1299331 Thymus SRR1299441 
Kidney SRR1536711 Pancreas SRR1299335 Thyroid ERR030872 
Liver ERR030887 Pancreas SRR1299336 
White Blood 
Cell 
ERR030875 
Liver SRR2040579 Pancreas SRR1299337     
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Table 3. Contribution of MEs by count to exonic regions 
ME Class  *CDS  5’-UTR 3’-UTR NR 
DNA 758 745 4271 14756 
LTR 810 1107 2906 18290 
LINE 2048 2066 7879 32734 
SINE 2970 3736 14713 51346 
SVA 41 17 38 219 
Total  6627 7671 29807 117345 
*Represents the count of all ME-CDS  
 
 
Figure 1. Contribution of ME in the transcriptome to each genomic region by chromosome 
A) Raw count of ME in the reference transcriptome; B) Percentage by class ME contribution to 
the reference transcriptome; C) ME-exon count normalized to the respective ME genomic count 
e.g. (ME exon count/ME genome count) 
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 Figure 2. Examples of conserved MEs contributing to CDS of evolutionary older species based on ME class. 
Screenshot of ME-CDS shown in the UCSC Genome Browsers with the gene structure and RepeatMasker tracks 
displayed. A) DNA transposon contributes to the PP3CC gene in zebrafish; B) LTR contributing to CK346298 
gene in Mouse; C) A LINE element contributes to CK69244 gene in zebrafish; D) SINE element contributing to a 
gene in Mouse.  
  
